Clinical trial Recruiting at 1 site Interventional Ages 18 and up Men only

Pelvic floor training for men with chronic pelvic pain

Official title: Long Term Effects of Pelvic Floor Re-education in Men With Chronic Pelvic Pain, Using Bio-feedback and Home Training - Subjective Outcomes in Correlation to Objective Measurements of the Lower Urinary Tract and Pelvic Floor

Run by Region Stockholm · NCT06115083 · Data updated 2026-11-12

This study is testing if pelvic floor exercises and biofeedback can help men with chronic pelvic pain feel better over six months compared to those who continue their usual treatment.

Quick facts

Study typeInterventional
Ages18 Years and up
SexMen only
Enrollment40 (estimated)
SponsorRegion Stockholm
Government
Locations1 site (Stockholm)
StatusRecruiting
StartedDecember 1, 2023
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedApril 16, 2024
Trial IDNCT06115083 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are men over 18 years old residing in Sweden, diagnosed with Chronic Primary Pelvic Pain Syndrome.

Probably not a fit

Patients with cancer in the abdomen or pelvic organs, congenital anomalies affecting the pelvic region, or those unable to participate due to mental incapacity or language difficulties may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled study aims to evaluate the long-term effects of pelvic floor re-education through biofeedback and home training in men suffering from chronic pelvic pain. Participants will engage in daily pelvic floor exercises for six months, complemented by biofeedback sessions, while their symptoms will be assessed using the National Institute of Health - Chronic Prostatitis Symptom Index. The study will also correlate subjective symptom improvements with objective measurements of pelvic floor function. A control group will maintain their current treatment without any new interventions during the study period.

Why it matters

Potential benefit: If successful, this approach could significantly improve the quality of life for men suffering from chronic pelvic pain by providing effective non-invasive treatment options.

How similar studies have gone: Other studies have shown promising results with pelvic floor training for chronic pelvic pain, indicating that this approach is supported by existing evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Men over the age of 18, residents in Sweden, diagnosed with Chronic Primary Pelvic Pain Syndrome (CPPPS) according to the International Statistical Classification of Diseases and Related Health Problems (ICD-10) (N41.1 (chronic prostatitis), N41.9 (Inflammatory disease of prostate, unspecified), N50.8F (Chronic Pelvic Pain Syndrome in men)

Exclusion Criteria:

* Cancer in the abdomen or pelvic organs (current or previous)
* Congenital anomalies affecting the pelvic region (Bladder exstrophy, Myelomeningocele etc.)
* Transsexual male, (i.e. at birth biologically female)
* Diseases affecting the nerve function to the pelvic and/or lower extremities, other disease or ongoing treatment that could have an impact on the outcome of the study.
* Incapability to participate in testing or follow training instructions due to mental incapacity, language difficulties etc.

Where it's running

  • Karolinska University Hospital
    Stockholm, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.